Stéphanie Mathis

490 total citations
16 papers, 141 citations indexed

About

Stéphanie Mathis is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Stéphanie Mathis has authored 16 papers receiving a total of 141 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 7 papers in Genetics and 4 papers in Immunology. Recurrent topics in Stéphanie Mathis's work include Acute Myeloid Leukemia Research (9 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Stéphanie Mathis is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Multiple Myeloma Research and Treatments (3 papers). Stéphanie Mathis collaborates with scholars based in France and Austria. Stéphanie Mathis's co-authors include Valérie Bardet, Nicolas Chapuis, Carol K. Clark, Timothy M. Lynch, Ludovic Suner, Faith E. Hughes, Donnie E. Slone, Michaëla Fontenay, Anna Raimbault and Julien Guy and has published in prestigious journals such as Journal of Clinical Investigation, Blood and EMBO Reports.

In The Last Decade

Stéphanie Mathis

13 papers receiving 136 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stéphanie Mathis France 9 73 37 24 23 22 16 141
Sushree Sangita Sahoo United States 6 91 1.2× 39 1.1× 8 0.3× 35 1.5× 37 1.7× 13 136
Sigrid Machherndl‐Spandl Austria 8 159 2.2× 63 1.7× 38 1.6× 87 3.8× 35 1.6× 36 248
Lena Rai United Kingdom 7 144 2.0× 27 0.7× 59 2.5× 37 1.6× 40 1.8× 8 273
Frank Heits Germany 5 55 0.8× 18 0.5× 34 1.4× 36 1.6× 16 0.7× 6 150
Christian Reicherts Germany 8 75 1.0× 17 0.5× 52 2.2× 22 1.0× 31 1.4× 24 149
Kevin Jestice United Kingdom 6 85 1.2× 28 0.8× 36 1.5× 22 1.0× 29 1.3× 8 178
Graeme Quest Canada 6 21 0.3× 25 0.7× 19 0.8× 32 1.4× 69 3.1× 11 137
Aidong Lu China 10 169 2.3× 16 0.4× 91 3.8× 51 2.2× 56 2.5× 40 249
Blandine Guffroy France 5 14 0.2× 11 0.3× 23 1.0× 12 0.5× 24 1.1× 11 128
Y L Tracey Chan United Kingdom 8 127 1.7× 30 0.8× 28 1.2× 24 1.0× 154 7.0× 10 296

Countries citing papers authored by Stéphanie Mathis

Since Specialization
Citations

This map shows the geographic impact of Stéphanie Mathis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Mathis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Mathis more than expected).

Fields of papers citing papers by Stéphanie Mathis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphanie Mathis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Mathis. The network helps show where Stéphanie Mathis may publish in the future.

Co-authorship network of co-authors of Stéphanie Mathis

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphanie Mathis. A scholar is included among the top collaborators of Stéphanie Mathis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphanie Mathis. Stéphanie Mathis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zhao, Lin‐Pierre, Emmanuelle Clappier, Matthieu Duchmann, et al.. (2025). Prognostic significance of monocytic-like phenotype in patients with AML treated with venetoclax and azacytidine. Blood Advances. 9(14). 3556–3565.
2.
Vianay, Benoît, Stéphanie Mathis, Sofiane Fodil, et al.. (2025). AML patient blasts exhibit polarization defects upon interaction with bone marrow stromal cells. EMBO Reports. 26(13). 3264–3279.
3.
Bordenave, Jennifer, David Michonneau, Nicolas Vallet, et al.. (2024). Deciphering bone marrow engraftment after allogeneic stem cell transplantation in humans using single-cell analyses. Journal of Clinical Investigation. 134(20). 2 indexed citations
4.
Fodil, Sofiane, Rathana Kim, Étienne Lengliné, et al.. (2024). Prospective feasibility of a minimal BH3 profiling assay in acute myeloid leukemia. Cytometry Part B Clinical Cytometry. 108(1). 86–94. 1 indexed citations
5.
Asli, Bouchra, Marie‐Thérèse Daniel, Stéphanie Mathis, et al.. (2022). Erythroblastic synartesis associated with lymphoproliferative disorder: There can be more than meets the eye. Clinical Immunology. 236. 108951–108951.
6.
Lemaire, Pierre, Stéphanie Mathis, Sylvain Clauser, et al.. (2022). Machine learning-based improvement of MDS-CBC score brings platelets into the limelight to optimize smear review in the hematology laboratory. BMC Cancer. 22(1). 972–972. 9 indexed citations
7.
Green, Alexa S., Charles Dussiau, Anna Raimbault, et al.. (2019). Phenotypic landscape of granulocytes and monocytes by multiparametric flow cytometry: A prospective study of a 1‐tube panel strategy for diagnosis and prognosis of patients with MDS. Cytometry Part B Clinical Cytometry. 98(3). 226–237. 10 indexed citations
8.
Raimbault, Anna, Raphaël Itzykson, Lise Willems, et al.. (2019). The fraction of CD117/c‐KIT‐expressing erythroid precursors predicts ESA response in low‐risk myelodysplastic syndromes. Cytometry Part B Clinical Cytometry. 96(3). 215–222. 6 indexed citations
9.
Raimbault, Anna, Sigrid Machherndl‐Spandl, Raphaël Itzykson, et al.. (2018). CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation. British Journal of Haematology. 184(4). 625–633. 11 indexed citations
10.
Raimbault, Anna, Cécile Pierre‐Eugène, Alexandra Rouquette, et al.. (2016). APG101 efficiently rescues erythropoiesis in lower risk myelodysplastic syndromes with severe impairment of hematopoiesis. Oncotarget. 7(12). 14898–14911. 10 indexed citations
12.
Mathis, Stéphanie, Nicolas Chapuis, Marc Maynadié, et al.. (2014). Comparison of cross-platform flow cytometry minimal residual disease evaluation in multiple myeloma using a common antibody combination and analysis strategy. Cytometry Part B Clinical Cytometry. n/a–n/a. 4 indexed citations
13.
Suner, Ludovic & Stéphanie Mathis. (2014). Disseminated cryptococcosis in bone marrow. Blood. 123(20). 3070–3070. 10 indexed citations
14.
Mathis, Stéphanie, Nicolas Chapuis, Marc Maynadié, et al.. (2014). Comparison of cross-platform flow cytometry minimal residual disease evaluation in multiple myeloma using a common antibody combination and analysis strategy. Cytometry Part B Clinical Cytometry. 88(2). 101–109. 9 indexed citations
15.
Chapiro, Élise, Iléana Antony‐Debré, Christophe Parizot, et al.. (2013). Sex chromosome loss may represent a disease‐associated clonal population in chronic lymphocytic leukemia. Genes Chromosomes and Cancer. 53(3). 240–247. 21 indexed citations
16.
Mathis, Stéphanie, Donnie E. Slone, Timothy M. Lynch, Faith E. Hughes, & Carol K. Clark. (2006). Use of Colonic Luminal Pressure to Predict Outcome After Surgical Treatment of Strangulating Large Colon Volvulus in Horses. Veterinary Surgery. 35(4). 356–360. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026